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Abstract
 
Two signaling pathways known to be essential for progression from immature to mature B cells
are BAFF receptor (BAFF-R) and the B cell receptor (BCR). Here, we first show that phos-
pholipase C (PLC)-
 
 
 
2 is required for a BAFF-R–mediated survival signal. Then, we have ex-
amined the question of whether the reduced number of mature B cells in PLC-
 
 
 
2
 
 
 
/
 
 
 
 mice is
caused by a defect in either BCR or BAFF-R signaling. We find that a PLC-
 
 
 
2 SH2 mutant,
which inhibits coupling between BCR and PLC-
 
 
 
2, fails to restore B cell maturation, despite
supporting BAFF-dependent survival. Therefore, our data suggest that the BAFF-R–mediated
survival signal, provided by PLC-
 
 
 
2, is not sufficient to promote B cell maturation, and that, in
addition, activation of PLC-
 
 
 
2 by BCR is required for B cell development.
Key words: cell differentiation • cell survival • B lymphocyte subsets • spleen • tumor necrosis 
factor
 
Introduction
 
Immature B cells that emigrate from the bone marrow to
the periphery are referred to as transitional B cells (for re-
views, see references 1–3). Accordingly, in the spleen, B
cell development proceeds through the transitional 1 (T1),
transitional 2 (T2), and mature follicular B cell stages (4).
Signaling through the B cell receptor (BCR) is required for
the development and maintenance of mature splenic B cells
(5–8). Indeed, deletion of the Ig
 
 
 
 cytoplasmic tail leads to a
severe block in the generation of peripheral B cells (9).
Moreover, loss of BCR expression by conditional IgM ab-
lation aborts development from the transitional to mature
B cell stage (10).
In addition to the BCR, signaling through BAFF recep-
tor (BAFF-R) has been recently shown to be critical for B
cell survival that regulates the number of follicular B cells
(for reviews, see references 11–13). A/WySnJ mice have a
mutated gene that encodes BAFF-R (14, 15). These mice,
like BAFF-deficient mice (16, 17), have a developmental
block at the T1 stage, suggesting that either differentiation
to the T2 stage and/or survival of T2 cells require BAFF-R
signaling. Therefore, defective signaling emanating from
either BCR or BAFF-R can cause a decrease in numbers of
mature follicular B cells.
We and others have recently demonstrated that abla-
tion of phospholipase C (PLC)-
 
 
 
2 results in reduced
numbers of follicular mature B cells and poor responses to
T-independent type 2 (TI-2) antigens (18, 19). Herein,
we have investigated the mechanism by which PLC-
 
 
 
2
promotes B cell maturation in the spleen. Given that
BAFF-R belongs to the same receptor family (TNF re-
ceptors) of CD40 (14), the possible link between BAFF-R
and PLC-
 
 
 
2 can be speculated by the previous observations
that CD40-mediated responses were significantly reduced
in PLC-
 
 
 
2
 
 
 
/
 
 
 
 B cells (18, 19). Hence, if the BAFF-R,
like CD40, utilizes PLC-
 
 
 
2, two alternative, but not nec-
essarily mutually exclusive, possibilities could be consid-
ered: (a) defective BCR signaling by loss of PLC-
 
 
 
2
causes an decrease in numbers of mature B cells; (b) this
decrease is mainly due to insufficient BAFF-R signaling
in PLC-
 
 
 
2
 
 
 
/
 
 
 
 B cells. After establishing the link between
BAFF-R and PLC-
 
 
 
2, we designed experiments to dis-
tinguish the above two possibilities. Our data suggest that
activation of PLC-
 
 
 
2 by BCR is essential for develop-
ment of mature B cells.
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-deoxyuridine; PLC, phospholipase C.T
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Materials and Methods
 
Mice.
 
Wild-type C57BL/6 mice were purchased from Clea
Japan. RAG-2
 
 
 
/
 
 
 
 mice were purchased from Taconic. PLC-
 
 
 
2
 
flox/flox
 
 mice (18) were crossed with CAG-Cre transgenic mice
(20) to obtain CAG-Cre/PLC-
 
 
 
2
 
 
 
/
 
 
 
 mice. Then these mice are
crossed with C57BL/6 mice to generate PLC-
 
 
 
2
 
 
 
/
 
 
 
 mice.
 
Flow Cytometry.
 
Cell surface expression of IgM and IgD was
analyzed by FACSCalibur™ (Becton Dickinson) as described
previously (18). FITC-conjugated anti-IgM was purchased from
BD Biosciences. PE-conjugated anti-IgD was purchased from
Southern Biotechnology Associates, Inc. Expression levels of
EGFP were also monitored by FACSCalibur™. Viability of the
cells was measured by staining dead cells with 1 
 
 
 
g/ml propid-
ium iodide (Sigma-Aldrich). Also apoptotic cells were detected
using PE-conjugated Annexin V (BD Biosciences) according to
the manufacturer’s instruction. Experiments were performed
at least three times and shown as mean 
 
  
 
SD in Fig. 2 A and
Fig. 4 A.
 
Preparation of T2 B Cells and Cell Culture.
 
T2 B cells were
purified from splenic B cells by cell sorting. Splenic B cells were
prepared as described previously (18). Then 5 
 
 
 
 10
 
7
 
 splenic B
cells were stained with FITC-conjugated anti-CD21, PE-conju-
gated anti-HSA, and biotinylated anti-CD23 combined with
streptavidin-CyChrome. T2 B cells (CD21
 
hi
 
HSA
 
hi
 
CD23
 
 
 
B220
 
 
 
)
were sorted using EPICS ALTRA (Beckman Coulter). Staining
with anti-CD21, anti-HSA, and anti-CD23 instead of anti-IgM
and anti-IgD was performed to avoid contamination of marginal
zone B cells and also in order to prevent potential activation sig-
nals through the BCR. Reanalysis of sorted T2 cell population
revealed 
 
 
 
90% purity. FITC-conjugated anti-CD21, PE-conju-
gated anti-HSA, biotinylated anti-CD23, and streptavidin-
CyChrome were purchased from BD Biosciences.
In vitro cultures of T2 B cells were performed according to
the previous reports (21, 22). In brief, 2–5 
 
 
 
 10
 
5
 
 sorted T2 B
cells were cultured in the growth medium consists of RPMI-
1640 medium (GIBCO™; Invitrogen) supplemented with 10%
FCS (Biological Industries), 50 
 
 
 
M 2-ME (Sigma-Aldrich), 2
mM 
 
l
 
-glutamine, 4 mM sodium pyruvate, and antibiotics
(GIBCO™; Invitrogen). Recombinant human BAFF (Research
Diagnostics Inc.) or anti-IgM F(ab
 
 
 
)
 
2
 
 (Jackson ImmunoResearch
Laboratories) was added where indicated.
 
Retroviral or Lentiviral Transduction of Bone Marrow Cells and T2
B Cells.
 
The cDNA encoding wild-type rat PLC-
 
 
 
2 or its SH2
mutant was cloned into both MSCV-based retroviral vector and
HIV based lentiviral vector. These vectors contain EGFP cDNA
as an expression marker downstream of the internal ribosomal en-
try site.
Culture supernatants containing retrovirus were generated us-
ing EcoPack2 packaging cell line (BD Biosciences). For activa-
tion of bone marrow cells, freshly isolated cells were cultured in
the growth medium supplemented with 10 ng/ml SCF, 20 ng/
ml IL-3 and 10 ng/ml IL-6 for 2 d. Activated bone marrow
cells were transduced with retrovirus using RetroNectin Dish
(TAKARA BIO) according to the manufacturer’s instruction. 2 d
after the infection, cells were collected and transferred into irradi-
ated recipient mice as described below. Both GFP
 
 
 
 and GFP
 
 
 
cells were transferred together without sorting in order to analyze
GFP
 
 
 
 cells as an internal control. SCF, IL-3, and IL-6 were pur-
chased from R&D Systems.
Culture supernatants containing the lentivirus were obtained
using Virapower Lentivirus Kit (Invitrogen) according to the
manufacturer’s instruction. Collected supernatants were then
centrifuged at 60,000 
 
g
 
 for 2 h and the virus pellets were resus-
pended in culture medium at 100:1 volume. Freshly isolated T2
B cells were transduced with lentivirus as follows. Sorted T2 B
cells were suspended in 250 
 
 
 
l of growth medium containing
polybrene (Sigma-Aldrich) at the concentration of 16 
 
 
 
g/ml in
24-well culture dish, followed by addition of 250 
 
 
 
l medium
containing lentivirus. Then the culture plates were centrifuged at
30
 
 
 
C, 2,500 rpm for 90 min. After 48–72 h culture, transduction
efficiencies were monitored by EGFP expression. For transduc-
tion using lentiviral vectors, 
 
 
 
60% of the cells were expressing
EGFP routinely after 48 h when examined by infecting wild-type
B cells.
 
Passive Transfer of Bone Marrow Cells.
 
For passive transfer of
bone marrow cells, recipients were 
 
 
 
-irradiated at the dose of 10
Gy, followed by i.v. injection of 10
 
6
 
 donor bone marrow cells.
For analysis of cell autonomous defect of PLC-
 
 
 
2
 
 
 
/
 
 
 
 bone mar-
row cells, RAG-2
 
 
 
/
 
 
 
 mice were injected i.v. with 5 
 
 
 
 10
 
6
 
 bone
marrow cells from wild-type or PLC-
 
 
 
2
 
 
 
/
 
 
 
 mice.
 
RT-PCR. 
 
Expression levels of BAFF receptor (BAFF-R) or
PLC-
 
 
 
2 were analyzed by semi-quantitative RT-PCR. In brief,
total RNA was extracted from 10
 
6
 
 cells using Trizol (Invitrogen).
Obtained RNA was reverse transcribed using random hexamer
(TAKARA BIO) with SuperScriptII (Invitrogen) according to
the manufacturer’s instruction. For amplification of BAFF-R,
5
 
 
 
-ACTGCGTGTCCTGTGAGCTCTT-3
 
 
 
 and 5
 
 
 
-TCTGGG-
CCAGCTGTCTTGGT-3
 
 
 
 were used as forward and reverse
primers, and cycled 35 times at 94
 
 
 
C 1 min, 55
 
 
 
C 1 min, and
72
 
 
 
C 1 min. For amplification of mouse or rat PLC-
 
 
 
2, 5
 
 
 
-AGG-
CCAGTGCTGACCAGCTG-3
 
 
 
 and 5
 
 
 
-CTGTGAGCCGCA-
GCTCGAA-3
 
 
 
 were used as forward and reverse primers, and
cycled 35 times at 94
 
 
 
C 1 min, 55
 
 
 
C 1 min, and 72
 
 
 
C 1 min. To
avoid detection of incomplete PLC-
 
 
 
2 mRNA expressed in cells
from PLC-
 
 
 
2
 
 
 
/
 
 
 
 mice, forward primer was designed within the
deleted exon (18). For amplification of bcl-2, 5
 
 
 
-TGCACCT-
GACGCCCTTCAC-3
 
 
 
 and 5
 
 
 
-TAGCTGATTCGACCATT-
TGCCTGA-3
 
 
 
 were used as forward and reverse primers, and
cycled 35 times at 94
 
 
 
C 1 min, 55
 
 
 
C 1 min, and 72
 
 
 
C 1 min.
GAPDH was amplified as an internal control using 5
 
 
 
-CCAT-
CACCATCTTCCAGGAG-3
 
 
 
 and 5
 
 
 
-CCTGCTTCACCAC-
CTTCTTG-3
 
 
 
 as forward and reverse primers.
 
5
 
 
 
-Bromo-2
 
 
 
-deoxyuridine Labeling.
 
5
 
 
 
-Bromo-2
 
 
 
-deoxyuri-
dine (BrdU) labeling was performed as reported previously (23). In
brief, mice were fed with BrdU (Wako Pure Chemical Industries)
in the drinking water at concentration of 1 mg/ml for 1 wk.
Spleen cells were depleted of non-B cells as described previously
(18). After staining with biotinylated anti-CD21 combined with
streptavidin-CyChrome and PE-conjugated anti-HSA, BrdU la-
beled T1, T2, and mature B cells were detected using BrdU Flow
Kit (BD Biosciences) according to the manufacturer’s instruction.
Calcium Measurement and Protein Analysis. Calcium mobiliza-
tion was measured as described previously (18) with several mod-
ifications. In brief, 5   107 spleen cells were loaded with 1.2  M
Indo 1-AM (Sigma-Aldrich) at 37 C for 45 min. Cells were
washed and stained with FITC-conjugated anti-CD21, PE-con-
jugated anti-HSA, and CyChrome-conjugated anti-B220. Then
106 stained cells were stimulated with 2  g/ml recombinant hu-
man BAFF or 15  g/ml anti-IgM F(ab )2. Continuous monitor-
ing of fluorescence from the cell suspension was performed using
BD-LSR (Becton Dickinson).
Stimulated splenic B cells (3   107) were solubilized and im-
munoprecipitated with anti-PLC- 2 (Santa Cruz Biotechnology,
Inc.) as described previously (18). Immunoprecipitates were sepa-
rated by 7.5% SDS-PAGE, blotted and detected by anti-phos-T
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photyrosine Ab, 4G10 (Upstate) using the enhanced chemilumi-
nescence system (Amersham Biosciences).
Preparation of Nuclear Extracts. Stimulated cells (5   106)
were washed with ice cold PBS and cell pellet was suspended in
800  l hypotonic buffer (10 mM HEPES, pH 7.9, 10 mM KCl,
0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT, 5  g/ml antipain,
5  g/ml aprotinin, 5  g/ml leupeptin, 0.5  g/ml pepstatin, and
0.5 mM PMSF) for 10 min on ice followed by addition of 50  l
of 10% NP-40. After vortexing for 20 s, nuclei were prepared by
centrifugation for 1 min at 15,000 rpm. Then the nuclear pellet
was suspended in 50  l of high buffer (20 mM HEPES, pH 7.9,
0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 5  g/
ml antipain, 5  g/ml aprotinin, 5  g/ml leupeptin, 0.5  g/ml
pepstatin, and 1 mM PMSF) and incubated for 20 min at 4 C
with continuous brief mixing. The mixture was then centrifuged
at 15,000 rpm for 5 min and the supernatants were subjected to
EMSA.
EMSA. Nuclear extracts (5  g of protein) were preincu-
bated in 28  l reaction volume containing 10 mM HEPES, pH
7.9, 50 mM KCl, 1 mM EDTA, 5% glycerol, 5 mM DTT, 250
 g/ml poly dI-dC (Amersham Biosciences) for 10 min at 4 C.
Then 2  l of 32P-labeled oligonucleotide (20,000 cpm) were
added and incubated for 20 min at room temperature. The sam-
ples were analyzed by electrophoresis in a 4% nondenaturing
polyacrylamide gel using 0.5  TBE. Double stranded oligonu-
cleotide containing NF- B binding site 5 -AGCTTCAACA-
GAGGGGACTTTCCGAGAGGCTCGAG-3  was used for
 B binding probe and double stranded oligonucleotide 5 -
TGTCGAATGCAAATCACTAGAA-3  was used for Oct-1
binding probe.
Results
Reduction in the Number of Mature B Cells in PLC- 2 / 
Mice Is Cell Autonomous. Given the recent evidence that
marginal zone (MZ) B cells in the spleen contribute to hu-
moral immune responses (24), we first examined whether
MZ B cells develop normally in PLC- 2 /  mice. As
shown in Fig. 1 A, the percentage of MZ B cells
(CD21hiCD23loB220 ) was comparable in the spleens be-
tween PLC- 2 /  and wild-type mice. Then, we ad-
dressed whether the reduced number of splenic follicular
mature B cells observed in PLC- 2 /  mice could result
from a cell autonomous defect or a defect in stromal mi-
croenvironment that supports the differentiation of these
cells. To distinguish between these possibilities, we per-
formed a cell transfer experiment. Fig. 1 B shows that the
transfer of bone marrow cells from wild-type mice into
RAG-2 /  recipients reconstituted normal number of
IgMloIgDhi mature B cells in the spleen. In contrast, bone
marrow cells derived from PLC- 2 /  mice transferred
into the RAG-2 /  recipients gave rise to a dramatic de-
crease in mature B cells, as seen in PLC- 2 /  mice.
Hence, we conclude that the mature B cell defect in PLC-
 2 /  mice is cell autonomous.
PLC- 2 Is Required for Both BCR- and BAFF-R–mediated
Survival of Immature B Cells. BCR ablation (10) or BAFF-R
mutation (14, 15) results in cell death by apoptosis. To de-
termine whether absence of mature B cell accumulation in
PLC- 2 /  mice is associated with cell death through a de-
fect in BCR or BAFF-R signaling, we measured survival of
immature B cells by using in vitro cultures in the presence
of anti-BCR Ab or BAFF. As T2 B cells, among the
splenic immature B cells, are thought to be the major target
for generating a survival signal such as through BAFF-R
(21, 25), T2 B cells from PLC- 2 /  mice and controls
were purified and cell death was measured by staining with
propidium iodide. Isolated PLC- 2 /  T2 B cells, after 48 h
culture in the absence of exogenous added agonists, exhib-
ited a two- to threefold decrease in the variability as mea-
sured by propidium iodide staining, compared with wild-
type T2 B cells (Fig. 2 A).
Consistent with previous reports, both BCR (22, 26, 27)
and BAFF-R (21, 25, 28) engagement promoted cell sur-
Figure 1. Reduction of mature B cell numbers in PLC- 2 /  mice is
cell autonomous. (A) Comparable number of marginal zone B cells in
wild-type and PLC- 2 /  mice. Total splenocytes from wild-type (left)
or PLC- 2 /  (right) mice were stained with indicated antibodies. Geno-
types are as indicated above and cell surface markers are shown as coordi-
nates. The numbers indicate the percentages of live cells in the lymphocyte
gate. Panels are representatives of four experiments. Average numbers of
total splenocytes in the wild-type and PLC- 2 /  mice are (5.8   0.5)  
107 and (4.7   0.4)   107, respectively. (B) FACS® analysis of reconsti-
tuted RAG-2 /  mice. 5   106 bone marrow cells from wild-type (left)
or PLC- 2 /  (right) mice were transferred i.v. into RAG-2 /  mice. 9
wk later, splenocytes were analyzed for the expression of IgM and IgD.
Panels are representatives of two experiments. Average numbers of total
splenocytes in RAG-2 /  mice reconstituted with wild-type and
PLC- 2 /  bone marrow cells are 3.2   107 and 2.3   107, respectively.T
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vival in T2 B cells from wild-type in a dose-dependent
manner. In contrast, these effects could not be detected in
T2 B cells from PLC- 2 /  mice (Fig. 2 A). Using an-
nexin V-staining as another cell death marker, essentially
the same data were obtained (unpublished data). The defect
in BCR- and BAFF-R–mediated survival of PLC- 2 / 
T2 B cells is not due to low levels of expression of these re-
ceptors, as cell surface expression of IgM (unpublished data)
Figure 2. Reduction of viability in T2 B cells from PLC- 2 /  mice.
(A) Viability of in vitro–stimulated wild-type or PLC- 2 /  T2 B cells.
Sorted T2 B cells from wild-type or PLC- 2 /  mice were stimulated
with indicated concentrations of anti-IgM F(ab )2 or BAFF for 48 h. Cul-
tured cells were stained with propidium iodide to distinguish live cells.
(B) Expression of BAFF-R mRNA in T2 B cells from wild-type and
PLC- 2 /  mice. Total RNA was extracted from sorted T2 B cells and
RT-PCR was performed as described in Materials and Methods. (C) In-
creased B cell turnover in the spleen of PLC- 2 /  mice. BrdU incorpora-
tion by T1, T2, and mature splenic B cells from wild-type or PLC- 2 / 
mice after 1 wk of BrdU administration in the drinking water was ana-
lyzed. Numbers indicate the percentages of BrdU-positive cells. Panels
are representatives of three independent experiments using at least three
mice each case. Average values of BrdU-positive cells in T1, T2, mature,
and total B cells are (89.1   0.4%, 13.1   2.0%, 6.5   0.5%, 24.9  
1.4%) for wild-type mice and (95.0   1.6%, 15.4   1.7%, 6.4   1.6%,
36.4   3.4%) for PLC- 2 /  mice, respectively.
Figure 3. Impaired NF- B activation in BCR- and BAFF-R–stimu-
lated PLC- 2 /  B cells. (A) Impaired nuclear translocation of NF- B in
BCR- or BAFF-R–stimulated B cells from PLC- 2 /  mice. Splenic B
cells from wild-type and PLC- 2 /  mice were stimulated with 10  g/
ml anti-IgM F(ab )2 for 4 h or with 2  g/ml BAFF for 12 h where indi-
cated. Nuclear extracts were prepared from stimulated B cells (5   106
cells/lane) and subjected to EMSA as described in Materials and Methods.
Oct-1binding is shown as a control. (B) Phosphorylation of PLC- 2 and
calcium mobilization in BCR- and BAFF-R–stimulated B cells. Splenic
B cells from wild-type mice (107 cells/lane) were stimulated with either
10  g/ml anti-IgM F(ab )2 or 2  g/ml BAFF for indicated periods. Ob-
tained cell lysates were immunoprecipitated with anti-PLC- 2 Ab and
analyzed by Western blotting with anti-phosphotyrosine antibody as de-
scribed in Materials and Methods (top). The same membrane was stripped
and reblotted with anti-PLC- 2 Ab. Splenic B cells from wild-type mice
were stimulated with 15  g/ml anti-IgM F(ab )2 or 2  g/ml BAFF and
calcium mobilization was measured as described in Materials and Methods
(bottom). (C) Impaired nuclear translocation of NF- B in BCR-stimu-
lated B cells reconstituted with PLC- 2 SH2 mutant. PLC- 2 /  splenic
B cells transduced with wild-type PLC- 2 (PLC- 2 (wt)) or its SH2 mu-
tant (PLC- 2 (SH2mt)) were recovered and subjected to EMSA. Oct-1
binding is shown as a control.T
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and mRNA expression of BAFF-R (Fig. 2 B) were not al-
tered between wild-type and PLC- 2 /  T2 B cells. To-
gether, we conclude that PLC- 2 plays an important role
in generating a survival signal emanating from both BCR
and BAFF-R. To further validate this conclusion, we de-
termined the percentage of BrdU-labeled B cells in the
spleens from PLC- 2 /  mice administered with BrdU.
When BrdU was fed for 1 wk, there was a marked increase
in the population of BrdU labeled B220  cells in PLC-
 2 /  mice compared with the wild-type mice (Fig. 2 C,
bottom). Particularly, BrdU labeled T1 and T2 B cells
were accumulated in the spleen of PLC- 2 /  mice, sug-
gesting that B cell turnover is enhanced in PLC- 2 / 
mice, consistent with the in vitro data described above.
BAFF-R–mediated Activation of NF- B Is Impaired in
PLC- 2 /  B Cells. It has been reported that stimulation
by both BCR and BAFF-R results in NF- B activation (5,
29). Thus, we next examined whether the nuclear translo-
cation of NF- B upon BCR or BAFF-R engagement is
dependent on PLC- 2. As reported, nuclear translocation
of NF- B was clearly seen in BCR- or BAFF-R–activated
wild-type B cells (Fig. 3 A). In contrast to wild-type, PLC-
 2 /  B cells displayed the lower level of NF- B binding
activity even before receptor stimulation. Moreover, trans-
location of NF- B was only marginally up-regulated in
PLC- 2 /  B cells after BCR or BAFF-R stimulation
(Fig. 3 A).
Although involvement of PLC- 2 in BAFF-R–medi-
ated signaling is clear, the manner in which PLC- 2 con-
tributes to this signaling appears to be distinct from the
case of BCR signal. As shown in Fig. 3 B, in contrast to
BCR cross-linking, BAFF-R stimulation did not induce
significant phosphorylation of PLC- 2 in wild-type B
cells. As a consequence, calcium was not mobilized by
BAFF-R stimulation.
A PLC- 2 SH2 Mutant Cannot Completely Promote B Cell
Development. The above results, given the absence of ma-
ture B cells in conditional IgM knockout mice (10) or
A/WySnJ (mutant BAFF-R) mice (14, 15), suggest that the
absence of mature B cells in PLC- 2 /  mice could arise
either as insufficiency of BCR or BAFF-R signaling, or
combination of both mechanisms. To dissect these possibil-
ities, we considered that a PLC- 2 SH2 mutant could be
useful. Both SH2 domains of PLC- 2 were previously
shown to be essential for coupling the BCR to cellular re-
sponses such as calcium mobilization and NF- B activation
(30, 31). Thus, we assumed that the PLC- 2 SH2 mutant
could provide the BAFF-R–mediated signal, at least to
some extent, despite shutting off the BCR signal. To verify
whether this assumption is correct, we examined the
BAFF-R–mediated survival of PLC- 2 /  T2 B cells re-
constituted with the PLC- 2 SH2 mutant. For this recon-
Figure 4. Restoration of BAFF-R–mediated survival of T2 B cells from
PLC- 2 /  mice by a PLC- 2 SH2 mutant. (A) Viabilities of T2 B cells
from PLC- 2 /  mice transduced with lentiviruses encoding either bcl-2,
wild-type PLC- 2, or its SH2 mutant. T2 B cells from PLC- 2 /  mice
were sorted as described in Materials and Methods. Obtained T2 B cells
without contamination of marginal zone B cells were infected with lentivi-
ruses encoding either bcl-2, wild-type PLC- 2, its SH2 mutant, or empty
vector followed by stimulation with 10  g/ml anti-IgM F(ab )2 (top), 2
 g/ml BAFF (middle), or 2  g/ml anti-CD40 mAb (bottom) for 48 h.
Infection efficiency achieved  60%, routinely. The empty vector encod-
ing only GFP was used as a negative control. Viabilities of cultured cells
were analyzed by propidium iodide staining. (B) Expression levels of
PLC- 2 mRNA and bcl-2 mRNA in transduced cells. To determine the
expression levels of PLC- 2 mRNA (top) and bcl-2 (bottom) in transduced
cells, RT-PCR was performed as described in Materials and Methods.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
586 A Role of Phospholipase C- 2 in B Cell Development
stitution, we employed a lentiviral-mediated gene transfer
method, because this method does not require preactiva-
tion of T2 B cells to make them susceptible to gene trans-
fer. As shown in Fig. 4 A (middle panel), the PLC- 2 SH2
mutant promoted the BAFF-mediated survival of T2 B
cells, although  25% less compared with wild-type PLC-
 2. As expected, this mutant failed to promote survival of
T2 B cells upon BCR engagement. As a positive control,
when wild-type PLC- 2 was introduced, both BCR- and
BAFF-R–mediated survival signals were restored. Survival
of CD40-activated T2 B cells was, at least to some extent,
promoted by the PLC- 2 SH2 mutant, suggesting that
PLC- 2 might be involved in not only BAFF-R–mediated
signaling pathway but also in some of other TNF receptors
in the similar way. Expression level of PLC- 2 mRNA in
transduced cells was determined by RT-PCR (Fig. 4 B).
To examine the in vivo consequences of the PLC- 2
SH2 mutant, we performed complementation experiments
with retroviruses carrying either wild-type PLC- 2 or its
SH2 mutant. These PLC- 2 cDNAs were cloned into the
Figure 5. Impaired develop-
ment of bone marrow cells from
PLC- 2 /  mice transduced
with a retrovirus encoding
PLC- 2 SH2 mutant. (A) Ret-
roviral infection of bone marrow
cells. Bone marrow cells from
PLC- 2 /  mice were infected
with retroviruses encoding either
wild-type PLC- 2 (PLC- 2
(wt)), its SH2 mutant (PLC- 2
(SH2mt)), or empty vector
(empty vector) as a negative con-
trol. After 2 d, 106 cultured bone
marrow cells were then injected
i.v. to irradiated wild-type mice
as described in Materials and
Methods. After 9 wk, GFP ex-
pression levels in splenocytes
from each reconstituted mice
were analyzed. Dashed lines in-
dicate the fluorescent levels of
uninfected splenocytes. Solid
lines indicate the fluorescent lev-
els of splenocytes from reconsti-
tuted mice. Bars indicate the
gates for analyzing GFP  cells
and GFP  cells in B. (B) Expres-
sion of IgM and IgD in reconsti-
tuted splenocytes. Total spleno-
cytes were analyzed without
gating (left) or after gating GFP 
cells (middle) and GFP- cells
(right) as indicated in (A). Total
splenocytes from the mice re-
constituted with wild-type bone
marrow cells were used as a posi-
tive control. The numbers indi-
cate the percentages of live cells
in the lymphocyte gates. Mean
percentages of IgMloIgDhi, IgMhi-
IgDhi, and IgMhiIgDlo cells calcu-
lated from three experiments are
(9.5   1.2%, 12.7   2.5%, 14.5  
3.2%) for PLC- 2 transduced
cells, (2.9   1.2%, 15.9   3.5%,
29.5   2.4%) for PLC- 2 SH2
mutant transduced cells, (3.2  
0.9%, 8.2   1.3%, 32.0   3.1%)
for control vector transduced
cells, and (38.3   4.2%, 15.0  
3.1%, 7.3   1.9%) for splenocytes reconstituted with wild-type bone marrow cells, respectively. Panels are representatives of three experiments. Average
numbers of total splenocytes in the mice reconstituted with wild-type PLC- 2, its SH2 mutant, empty vector infected bone marrow cells calculated from
three experiments are (3.4   0.3)   107, (3.1   0.5)   107, and (2.8   0.8)   107, respectively. (C) Calcium mobilization in retrovirally transduced B
cells. Bone marrow cells from PLC- 2 /  mice were transduced with retroviruses encoding either wild-type PLC- 2 (PLC- 2 (wt)), its SH2 mutant
(PLC- 2 (SH2)), or empty vector (empty vector) and injected to irradiated wild-type mice. After 9 wk, reconstituted splenic B cells from each mice
were stimulated with 15  g/ml anti-IgM F(ab )2 and calcium mobilization was measured as described in Materials and Methods.T
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MSCV vector containing an internal ribosomal entry site,
which results in the generation of a bicistronic mRNA en-
coding GFP at its 3  end. Bone marrow cells isolated from
PLC- 2 /  mice were infected with these retroviruses and
then injected into lethally irradiated mice. Efficiency of ret-
rovirus infection ranged from 45% to 75% (unpublished
data). After 9 wk, 25% to 40% of the spleen cells from re-
constituted mice were GFP  (Fig. 5 A). Representative
data from three experiments are shown in Fig. 5 B. FACS®
analysis of spleen cells demonstrated that wild-type PLC-
 2, but not its SH2 mutant, was able to correct the matura-
tion defect in PLC- 2 /  B cells. Although requirement
for the PLC- 2 SH2 domains in development of IgMlo-
IgDhi mature population is clear, a reproducible increase,
albeit small, of IgMhiIgDhi population was observed in mice
reconstituted with the PLC- 2 SH2 mutant, compared
with control mice. GFP  cells showed similar expression
pattern of IgM and IgD as PLC- 2 /  mice in every case.
Collectively, these results suggest that the BAFF-R–medi-
ated survival signal, provided by PLC- 2, contributes, in
part, to the survival of immature B cells, but is not suffi-
cient to promote B cell maturation. Further development
into mature B cells is therefore likely to require the BCR
signal through PLC- 2. Indeed, shutting off the BCR sig-
nal by the PLC- 2 SH2 mutant was confirmed by both
calcium and NF- B data (Figs. 5 C and 3 C).
When bcl-2 was introduced to PLC- 2 /  T2 B cells by
lentiviruses, the viability was significantly increased in the
absence of exogenous agonists (Fig. 4 A). This result is well
consistent with the concept that Bcl-2 expression delays
apoptotic cell death in many cell types including mature B
cells that have lost their receptors by Ig  deletion (10).
Thus, to examine whether the survival signal emanating
from BCR and BAFF-R is sufficient for B cell maturation,
we performed a passive transfer experiment of PLC- 2 / 
bone marrow cells infected with a retrovirus encoding bcl-2.
RT-PCR analysis of the infected splenic B cells demon-
strated that the expression level of bcl-2 was 5–10 times
higher than that in control wild-type B cells (unpublished
data). As shown in Fig. 6 B, transduction of PLC- 2 / 
Figure 6. Impaired develop-
ment of bone marrow cells from
PLC- 2 /  mice transduced
with a retrovirus encoding bcl-2.
(A) Retroviral infection of bone
marrow cells. Like in Fig. 5, bone
marrow cells from PLC- 2 / 
mice were infected with retrovi-
ruses encoding either wild-type
PLC- 2 (PLC- 2 (wt)), bcl-2
(bcl-2), or empty vector (empty
vector) as a negative control.
Dashed lines indicate the fluores-
cent levels of uninfected spleno-
cytes. Solid lines indicate the flu-
orescent levels of splenocytes
from reconstituted mice. Bars in-
dicate the gates for analyzing
GFP  cells and GFP- cells in B.
(B) Expression of IgM and IgD
in reconstituted splenocytes. Re-
constituted splenocytes were an-
alyzed as in Fig. 4. The numbers
indicate the percentages of live
cells in the lymphocyte gates.
Mean percentages of IgMloIgDhi,
IgMhiIgDhi, and IgMhiIgDlo cells
calculated from three experi-
ments are (11.2   1.4%, 11.3  
2.3%, 13.5   3.4%) for PLC- 2
transduced cells, (6.9   2.1%,
18.7   3.1%, 15.5   1.2%) for
bcl-2 transduced cells, (2.9  
0.7%, 7.9   1.1%, 30.8   2.9%)
for control vector transduced
cells, and (35.8   2.9%, 7.9  
1.1%, 2.9   0.7%) for spleno-
cytes reconstituted with wild-
type bone marrow cells. Panels
are representatives of three ex-
periments. Average numbers of
total splenocytes in the mice re-
constituted with bone marrow cells transduced with retroviruses encoding either wild-type PLC- 2, bcl-2, or empty vector calculated from three exper-
iments are (3.4   0.3)   107, (3.9   0.3)   107, and (2.8   0.8)   107, respectively.T
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precursor cells with bcl-2 could not completely rescue the
B cell development, suggesting that PLC- 2 mediates an
additional signal, presumably a differentiation signal, from
BCR to promote B cell maturation.
Discussion
Here, we have demonstrated that the loss of mature folli-
cular B cells in PLC- 2 /  mice is intrinsic to B cells.
Thus, it is most likely that a cell surface receptor on B lym-
phocytes signals to activate PLC- 2 in order for develop-
ment of mature B cells. In this regard, BAFF-R has re-
cently emerged as an important receptor in transition from
T1 B cells to mature B cells (11–13). Survival of PLC- 2 / 
T2 B cells following BAFF treatment was almost com-
pletely abolished. This could be explained by two possibili-
ties: (a) BAFF-R utilizes PLC- 2 to exert its survival signal
presumably through the NF- B pathway; (b) this defective
survival signal reflects more general signaling perturbation
induced by loss of PLC- 2. The first possibility seems to be
more likely, because PLC- 2 /  T2 B cells, like wild-type
cells, proliferate after LPS treatment (18, 19).
The coupling mechanism between BAFF-R and PLC- 2
appears to differ from the case of BCR. In contrast to BCR
stimulation, BAFF was not able to induce tyrosine phos-
phorylation of PLC- 2 and subsequent calcium mobiliza-
tion (32), simply suggesting that PLC- 2 contributes to
BAFF-R signaling in a lipase-independent manner. Given
the importance of PLC- 2 SH3 domain, but not its lipase
activity, in agonist-induced activation of calcium entry,
PLC- 2 might play a structural role in BAFF-R signaling.
Our data suggest the importance of the BAFF-R-medi-
ated survival signal, provided by PLC- 2, in expansion of
immature B cells in vivo, as the PLC- 2 SH2 mutant
(which supports BAFF-mediated survival) promoted an in-
crease in IgMhiIgDhi immature, but not IgMloIgDhi mature
B cells. These findings, together with the evidence that our
in vitro culture system, similar to a report by Batten et al.
(21), could induce differentiation of T2 B to mature B cells
in costimulation of anti-BCR Ab and BAFF (unpublished
data), might support the proposed idea that BAFF primarily
functions to survive immature B cells (21), rather than that
BAFF plays a direct role in maturation from immature to
mature B cells (28). Although we interpret expansion of
immature B cells by the PLC- 2 SH2 domain as restora-
tion of BAFF-R signal, our data cannot completely ex-
clude the possibility that this PLC- 2 mutant mediates sig-
naling emanating from an yet unidentified receptor,
thereby manifesting this phenotype.
Based on the evidence that mature B cells, upon induc-
ible deletion of BCR, undergo programmed cell death, it
has been proposed that BCR generates a survival signal
(10). Two models for explaining how BCR expression
might protect B cells from apoptosis have been thought:
first, receptor assembly on the cell surface might be suffi-
cient to produce a constitutive survival signal; alternatively,
the tonic signal might be produced by low-affinity interac-
tion between BCR and self-antigens. Although our exper-
iments do not distinguish these two possibilities, cross-link-
ing of BCR is thought to mimic some aspects of this BCR
function, because it protects them from apoptosis. Hence,
our data suggest that PLC- 2 mediates the survival signal
emanating from the BCR by an SH2-dependent manner.
PLC- 2–mediated hydrolysis of PIP2 generates IP3 and
DAG, which trigger two parallel pathways that lead to a
rise in cytoplasmic Ca2  and activation of PKC . Given
the requirement for PKC  in BCR-mediated survival
through IKK activation (27, 33), the defective BCR-medi-
ated survival in PLC- 2 /  T2 B cells could be explained
by the PKC  axis.
However, the survival signal, by itself, appears not to be
sufficient, as bcl-2 overexpression cannot completely rescue
the B cell development in PLC- 2 /  cells (Fig. 6). Hence,
we propose that PLC- 2 conveys two signals, survival and
differentiation, from BCR, both of which are sequentially
or concomitantly required for mature B cell development.
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